Literature DB >> 20347930

HMGA2: A pituitary tumour subtype-specific oncogene?

Monica Fedele1, Dario Palmieri, Alfredo Fusco.   

Abstract

The high mobility group AT-hook (HMGA) proteins, a family of DNA architectural factors, are highly expressed during embryogenesis and play a crucial role in several different biological processes, as well as in tumorigenesis of a wide range of tissues, including pituitary. Indeed, HMGA2 has been found rearranged and amplified in human prolactinomas, and transgenic mice overexpressing either Hmga1 or Hmga2 develop pituitary adenomas secreting prolactin and growth hormone. Here, we overview HMGA proteins in human tumours, focusing on pituitary adenomas and the mechanisms by which the HMGA proteins are involved in their onset and development. Different HMGA-dependent potential drives of pituitary oncogenesis are discussed as future research directions in the field. 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347930     DOI: 10.1016/j.mce.2010.03.019

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  34 in total

1.  Elevated expression of HMGA1 correlates with the malignant status and prognosis of non-small cell lung cancer.

Authors:  Ze Zhang; Quan Wang; Feng Chen; Jun Liu
Journal:  Tumour Biol       Date:  2014-10-25

2.  Genomic analyses identify agents regulating somatotroph and lactotroph functions.

Authors:  Jun Fan; Cui Zhang; Qi Chen; Jin Zhou; Jean-Louis Franc; Qing Chen; Yunguang Tong
Journal:  Funct Integr Genomics       Date:  2016-10-05       Impact factor: 3.410

3.  Downregulation of miR-410 targeting the cyclin B1 gene plays a role in pituitary gonadotroph tumors.

Authors:  Paula Müssnich; Gerald Raverot; Marie-Lise Jaffrain-Rea; Filippo Fraggetta; Anne Wierinckx; Jacqueline Trouillas; Alfredo Fusco; Daniela D'Angelo
Journal:  Cell Cycle       Date:  2015-06-30       Impact factor: 4.534

4.  Histone Citrullination Represses MicroRNA Expression, Resulting in Increased Oncogene mRNAs in Somatolactotrope Cells.

Authors:  Stanley B DeVore; Coleman H Young; Guangyuan Li; Anitha Sundararajan; Thiruvarangan Ramaraj; Joann Mudge; Faye Schilkey; Aaron Muth; Paul R Thompson; Brian D Cherrington
Journal:  Mol Cell Biol       Date:  2018-09-14       Impact factor: 4.272

5.  Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells.

Authors:  Mark O Kitchen; Kiren Yacqub-Usman; Richard D Emes; Alan Richardson; Richard N Clayton; William E Farrell
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

6.  Probing into the biological processes influenced by ESC factor and oncoprotein HMGA2 using iPSCs.

Authors:  Amir Morshedi; Zhonglu Ren; Jinming Li; Peter Dröge
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

7.  mTOR promotes pituitary tumor development through activation of PTTG1.

Authors:  R Chen; J Duan; L Li; Q Ma; Q Sun; J Ma; C Li; X Zhou; H Chen; Y Jing; S Zhao; X Wu; H Zhang
Journal:  Oncogene       Date:  2016-08-15       Impact factor: 9.867

8.  Expression of HMGA2 in bladder cancer and its association with epithelial-to-mesenchymal transition.

Authors:  X Ding; Y Wang; X Ma; H Guo; X Yan; Q Chi; J Li; Y Hou; C Wang
Journal:  Cell Prolif       Date:  2014-02-26       Impact factor: 6.831

Review 9.  Gene expression in prolactinomas: a systematic review.

Authors:  Justin Seltzer; Thomas C Scotton; Keiko Kang; Gabriel Zada; John D Carmichael
Journal:  Pituitary       Date:  2016-02       Impact factor: 4.107

10.  Oncofetal protein IGF2BP3 facilitates the activity of proto-oncogene protein eIF4E through the destabilization of EIF4E-BP2 mRNA.

Authors:  R Mizutani; N Imamachi; Y Suzuki; H Yoshida; N Tochigi; T Oonishi; Y Suzuki; N Akimitsu
Journal:  Oncogene       Date:  2015-11-02       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.